Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Overview of annual performance metrics for index funds highlights consistency and risk-adjusted returns to inform choices.
21,807 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Title insurance premium volume surged nearly 14% in 2025, driven by stronger mortgage activity and ongoing demand for...
When insiders move stock, investors pay attention. This article breaks down what iradimed’s founder sold 7,500 means ...
A sudden rise in sweetgreen stock often stirs chatter among traders and fans alike. This article explains the common ...
Stablecoins are changing how money moves, and traditional payment stocks face new challenges and opportunities. This ...
Two bold players are trying to reinvent how nuclear power sits in the grid. This guide breaks down Nano Nuclear Energ...
Two pharma giants are wighting for a leadership position in immunology. This piece explains why Johnson Johnson hopes...
U.S. health insurers rise as analysts forecast margin recovery and cost discipline. Humana jumps, UnitedHealth climbs...
A new study shows that choosing to retire at 62 can shave roughly $250,000 from lifetime income, while rising cogniti...
ARTY, the AI infrastructure ETF, surged as investors await the next round of hyperscaler capex guidance. The hypersca...
Optics stocks rally as AI infrastructure demand returns, led by Applied Optoelectronics with notable moves in LUMENTU...
An Axcelis VP Corporate Controller sold 2,574 shares for roughly $422k. This article breaks down what that means, how...